The closing price of Astria Therapeutics Inc (NASDAQ: ATXS) was $10.81 for the day, down -4.00% from the previous closing price of $11.26. On the day, 588080 shares were traded.
Ratios:
Our analysis of ATXS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.73 and its Current Ratio is at 21.73. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on March 28, 2023, initiated with a Outperform rating and assigned the stock a target price of $18.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 01 ’24 when Morabito Christopher sold 10,000 shares for $13.59 per share. The transaction valued at 135,939 led to the insider holds 0 shares of the business.
PERCEPTIVE ADVISORS LLC bought 2,481,350 shares of ATXS for $29,999,522 on Feb 01 ’24. The Director now owns 4,873,721 shares after completing the transaction at $12.09 per share. On Jan 29 ’24, another insider, Morabito Christopher, who serves as the Chief Medical Officer of the company, sold 9,200 shares for $11.15 each. As a result, the insider received 102,552 and left with 0 shares of the company.
Stock Price History:
Over the past 52 weeks, ATXS has reached a high of $16.90, while it has fallen to a 52-week low of $4.26.
Shares Statistics:
A total of 54.90M shares are outstanding, with a floating share count of 44.56M. Insiders hold about 18.84% of the company’s shares, while institutions hold 69.25% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by Atossa Therapeutics, Inc. analysts. The consensus estimate for the next quarter is $2.18, with high estimates of $0.14 and low estimates of $61.91.
Analysts are recommending an EPS of between $Healthcare and $Financial Services for the fiscal current year, implying an average EPS of $Communication Services.
